Project Grant R01MD020595
- The National Institute for Minority Health and Health Disparities awarded Michigan State University $1,269,874 on July 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to refine and test a patient-reported outcome measure (PROM) called Urgent Maternal Warning Signs for identifying severe maternal morbidity (SMM) in the postpartum period. The project addresses gaps in early detection of postpartum SMM, which accounts for approximately two-thirds of maternal...
- The National Institute for Minority Health and Health Disparities awarded The Regents of the University of California, San Francisco $2,306,030 on September 13, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct research on hypertension retention and cardiovascular risk reduction among people with HIV who use safety-net clinics. The recipient will conduct an explanatory sequential study combining quantitative survey data and qualitative contextual...
- The National Institute on Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $5,959,150 on September 14, 2025, for a randomized controlled trial examining the effectiveness of a food-is-medicine intervention to promote healthy eating and blood pressure control in hypertensive Black women with obesity. The FIM+DASH trial will deliver cooking classes, nutrition and hypertension education, and...
- The National Heart, Lung, and Blood Institute awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $232,156 on August 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop physics- and image-based patient-specific computer models that predict the risk of left ventricular outflow tract obstruction in transcatheter mitral valve replacement procedures. The research addresses a critical limitation in current...
- The National Heart, Lung, and Blood Institute awarded the University of Mississippi Medical Center $333,250 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot-test a home blood pressure monitoring intervention for rural Mississippi. The recipient will modify a validated chronic disease self-management program that combines longitudinal home blood pressure monitoring with a smartphone-delivered virtual agent providing personalized education. The...
- The National Heart, Lung, and Blood Institute awarded the Regents of the University of Michigan $942,143 on September 25, 2025, to evaluate implementation of the World Health Organization's HEARTS hypertension and diabetes primary care model in Guatemala's Ministry of Health system under Assistance Listing 93.837 (Cardiovascular Diseases Research). The University of Michigan study team will conduct a mixed-methods evaluation spanning a 30-month implementation period followed by a 30-month...
- The National Institute for Minority Health and Health Disparities awarded the Regents of the University of Michigan $134,730 under the Minority Health and Health Disparities Research program (CFDA 93.307) on July 29, 2026, to support community-engaged research on heat preparedness among patients with chronic health conditions. Dr. Chandanabhumma, an early career researcher, will conduct mixed-methods research to adapt and test a community health worker–led intervention designed to enhance...
- The National Institute for Minority Health and Health Disparities awarded The University of Texas Southwestern Medical Center $1.347 million on July 18, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to test the efficacy of a family-level hypertension self-management intervention for African American primary care patients. The project, titled "WALK TOGETHER Trial," will conduct a randomized controlled study of a novel dyadic intervention delivered...
- The National Institute for Minority Health and Health Disparities awarded Kaiser Foundation Hospitals (Kaiser Permanente) $10.492 million on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds a mixed-methods implementation science study examining racial and ethnic disparities in depression treatment and outcomes across five health systems in seven states (California, Texas, Georgia, Minnesota, Michigan, North Dakota, and...
- The National Heart, Lung, and Blood Institute awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $1,099,000 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop precision circadian medicine solutions for shift workers managing shift work disorder. The award funds research scaling digital health technologies, including consumer-based wearables, to track and manage circadian rhythms in nightshift...
The National Institute for Minority Health and Health Disparities awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $793,318 on July 28, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a single-blind, randomized controlled trial evaluating team-based hypertension care for racial and ethnic minority populations. The study, titled EDIT-SBP (Emergency Department-Initiated, Team-Based Care to Reduce Severely Elevated Blood Pressure), will enroll 530 patients with severe hypertension (systolic blood pressure at or above 180 mm Hg and/or diastolic blood pressure at or above 110 mm Hg) across three emergency departments in metro Detroit, Michigan serving diverse communities. The intervention integrates clinical pharmacists and virtual primary care through a collaborative practice agreement that enables pharmacists to initiate and adjust antihypertensive therapy, supported by home blood pressure monitoring. Treatment begins in the emergency department with initial therapy and structured handoff to ongoing team-based management. The trial will assess whether the intervention improves blood pressure control, reduces emergency department reliance, decreases adverse clinical events, and demonstrates cost-effectiveness compared to usual care. Performance occurs in East Lansing, Michigan, with the award period running through December 31, 2030. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $793.3k | 7/30/26 |